ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020
Response to "Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment".
Anne B Brooks et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.